Pilot study of Sirolimus (rapamycin) as primary immunosuppression following liver transplantation.

被引：0
|
作者：
Crosbie, OM [1 ]
Collier, J [1 ]
Bateman, E [1 ]
Watson, CJ [1 ]
Calne, R [1 ]
Gimson, AE [1 ]
Alexander, GJ [1 ]
机构：
[1] Univ Cambridge, Sch Clin Med, Cambridge, England
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
100
引用
收藏
页码：185A / 185A
页数：1
相关论文
共 50 条
  • [1] Experience with sirolimus (rapamycin) as primary immunosuppression post liver transplantation.
    Mallat, DB
    O'Brien, CB
    Rodriguez, MJ
    Pinna, AD
    Nery, JR
    Kato, T
    Schiff, ER
    Tzakis, AG
    HEPATOLOGY, 2000, 32 (04) : 343A - 343A
  • [2] Primary sirolimus based immunosuppression allows delayed use of CNI in liver transplantation.
    Lorf, T
    Weichhold, HE
    Binder, L
    Ramadori, G
    Quintel, M
    Becker, H
    LIVER TRANSPLANTATION, 2005, 11 (07) : C44 - C44
  • [3] The Impact of Sirolimus Immunosuppression on Recurrent Hepatitis C after Liver Transplantation.
    Asthana, Sonal
    Toso, Christian
    Meeberg, Glenda
    Mason, Andrew
    Bigam, David L.
    Shapiro, Andrew M. J.
    Kneteman, Norman M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 347 - 348
  • [4] Sirolimus as maintenance immunosuppression in pediatric intestinal transplantation.
    Safta, Arica M.
    Castillo, Ricardo O.
    Cox, Kenneth
    Esquivel, Carlos O.
    PEDIATRIC TRANSPLANTATION, 2007, 11 : 78 - 78
  • [5] Mycophenolate mofetil with cyclosporine and prednisone as effective primary immunosuppression in children following liver transplantation.
    Lightdale, J
    Renz, JF
    Ascher, NL
    Emond, JC
    Rosenthal, P
    GASTROENTEROLOGY, 1997, 112 (04) : A1320 - A1320
  • [6] Sirolimus as a risk factor for incisional hernia following liver transplantation.
    Barnes, MT
    Singh, G
    Jabbour, N
    Genyk, Y
    Sher, L
    Selby, RR
    Mateo, R
    JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (01) : S164 - S164
  • [7] Everolimus maintenance immunosuppression for acute rejection following liver transplantation.
    Cheung, Fiona
    Li, Hanlin
    Tsapepas, Demetra
    Martin, Spencer
    Powell, Jaclyn
    PHARMACOTHERAPY, 2013, 33 (10): : E295 - E295
  • [8] Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma
    Zimmerman, Michael A.
    Trotter, James F.
    Wachs, Michael
    Bak, Tom
    Campsen, Jeffrey
    Skibba, Afshin
    Kam, Igal
    LIVER TRANSPLANTATION, 2008, 14 (05) : 633 - 638
  • [9] Minimizing immunosuppression in pediatric liver transplantation.
    Turmelle, Y.
    Nadler, M.
    Anderson, C.
    Lowell, J.
    Shepherd, R.
    PEDIATRIC TRANSPLANTATION, 2007, 11 : 111 - 111
  • [10] SIROLIMUS-BASED IMMUNOSUPPRESSION HAS NO INFLUENCE ON RECURRENT PRIMARY SCLEROSING CHOLANGITIS FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION
    Kaplan, Maria
    Mara, Kelly
    Wachs, Michael
    Bak, Thomas
    Nydam, Trevor L.
    Kam, Igal
    Zimmerman, Michael A.
    HEPATOLOGY, 2011, 54 : 652A - 653A
12345